Eben Rosenthal is a surgeon-scientist who serves as the Guy Maness Professor and Chair of Otolaryngology. His primary interests are free flap surgery and molecular imaging. He continues to be clinically active as an oncologic and microvascular reconstructive surgeon. He was previously the John and Ann Doerr Medical Director of the Stanford Cancer Center from 2015-2021.

Dr. Rosenthal has been continually funded by the NIH for the past 15 years to conduct bench to bedside translational studies in targeted therapy and molecular imaging. He has conducted over a dozen early phase clinical trials for diagnostic and therapeutic agents for the treatment of solid tumors. He is part of a multidisciplinary team of clinicians and basic scientists that perform preclinical animal studies including nonhuman primate IND-enabling studies, and first-in-human clinical trials. The team assesses near infrared fluorescent contrast agents for use in the operating room to make the cancer visible. Ongoing clinical trials include brain, lung, pancreas, skin and head and neck tumors. The lab also focuses on molecular imaging of fluorescently labeled therapeutic antibodies to measure cellular delivery of therapies to tumors and adjacent tissues.